Mon panier

Neuropilin-1

Neuropilin-1 Informations sur la molécule

Nom anglaisNeuropilin-1Nombre de médicaments commercialisés0
Nombre de médicaments cliniques1Alias de la cibleBDCA4,NP1,Neuropilin-1,NRP1,CD304,VEGF165R,Neuropilin 1,Vascular Endothelial Cell Growth Factor 165 Receptor,NRP,Transmembrane Receptor,CD304 Antigen
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisNeuropilin-1
Alias de la cibleBDCA4,NP1,Neuropilin-1,NRP1,CD304,VEGF165R,Neuropilin 1,Vascular Endothelial Cell Growth Factor 165 Receptor,NRP,Transmembrane Receptor,CD304 Antigen
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques1
Phase de R&D la plus avancéePhase 2 Clinical

Neuropilin-1 Liste de produits

  • Attribut

    Protein (5)

  • Bibliothèque de produits

    En ligne (5)

  • Espèces

    Human (3)Mouse (2)

  • Étiquette

    His Tag (2)Fc Tag (1)His Tag & Avi Tag (1)Mouse IgG Fc Tag (1)

  • Marqueur

    Unconjugated (4)Biotin-labeled (1)

Neuropilin-1Contexte de la molécule

Neuropilin-1 (NRP1) is also known as Vascular endothelial cell growth factor 165 receptor (VEGF165R), CD antigen CD304, which belongs to the neuropilin family. The membrane-bound isoform 1 is a receptor involved in the development of the cardiovascular system, in angiogenesis, in the formation of certain neuronal circuits and in organogenesis outside the nervous system. It mediates the chemorepulsant activity of semaphorins. It binds to semaphorin 3A, The PLGF-2 isoform of PGF, The VEGF-165 isoform of VEGF and VEGF-B. Coexpression with KDR results in increased VEGF-165 binding to KDR as well as increased chemotaxis. It may regulate VEGF-induced angiogenesis. The soluble isoform 2 binds VEGF-165 and appears to inhibit its binding to cells.

Neuropilin-1Alias de la molécule

NRP1,Neuropilin-1,NRP,VEGF165R,CD304

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
CertepetideCEND-1; iRGD; CIND-1; LSTA1; QLC12102; LSTA-1Phase 2 ClinicalDrugcendr IncAppendiceal Neoplasms; Bile Duct Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colonic Neoplasms; Colorectal Neoplasms; Gallbladder Neoplasms; Neoplasm Metastasis; Pancreatic Neoplasms; Triple Negative Breast Neoplasms
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques